Phosgene Poisoning Caused by the Use of Chemical Paint Removers Containing Methylene Chloride in Ill-Ventilated Rooms Heated by Kerosene Stoves

le Gerritsen, W. B., Buschmann, C. H.
Foilsithe 1960

Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy

le Drake, CG, Sharma, P, Gerritsen, W
Foilsithe in Oncogene (2013)

Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL

le Abou El Hassan, M A I, Mastenbroek, D C J, Gerritsen, W R, Giaccone, G, Kruyt, F A E
Foilsithe 2004

S48. Biomarker development for ipilimumab and prostate GVAX treatment

le de Gruijl, T, Santegoets, S, Stam, A, Lougheed, S, Jooss, K, Sacks, N, Harding, T, Hege, K, Gerritsen, W, van den Eertwegh, A
Foilsithe 2014

Redirecting Coronavirus to a Nonnative Receptor through a Virus-Encoded Targeting Adapter

le Verheije, M. H., Würdinger, T., van Beusechem, V. W., de Haan, C. A. M., Gerritsen, W. R., Rottier, P. J. M.
Foilsithe 2006

Cloning and characterization of human liver cytosolic beta-glycosidase.

le de Graaf, M, van Veen, I C, van der Meulen-Muileman, I H, Gerritsen, W R, Pinedo, H M, Haisma, H J
Foilsithe 2001

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

le Geoerger, B, Grill, J, Opolon, P, Morizet, J, Aubert, G, Lecluse, Y, van Beusechem, V W, Gerritsen, W R, Kirn, D H, Vassal, G
Foilsithe 2003

A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug

le de Graaf, M, Boven, E, Oosterhoff, D, van der Meulen-Muileman, I H, Huls, G A, Gerritsen, W R, Haisma, H J, Pinedo, H M
Foilsithe 2002

Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody

le Würdinger, T, Verheije, M H, Raaben, M, Bosch, B J, de Haan, C A M, van Beusechem, V W, Rottier, P J M, Gerritsen, W R
Foilsithe in Gene Ther (2005)

Advances in targeted alpha therapy for prostate cancer

le De Vincentis, G, Gerritsen, W, Gschwend, J E, Hacker, M, Lewington, V, O’Sullivan, J M, Oya, M, Pacilio, M, Parker, C, Shore, N, Sartor, O
Foilsithe in Ann Oncol (2019)

S100 protein content of umbilical cord blood in healthy newborns in relation to mode of delivery

le Wirds, J, Duyn, A, Geraerts, S, Preijer, E, van Diemen-Steenv..., J A A M, van Leeuwen, J H S., Haas, F, Gerritsen, W, de Boer, A, Leusink, J
Foilsithe 2003

Secreted and tumour targeted human carboxylesterase for activation of irinotecan

le Oosterhoff, D, Pinedo, H M, van der Meulen, I H, de Graaf, M, Sone, T, Kruyt, F A, van Beusechem, V W, Haisma, H J, Gerritsen, W R
Foilsithe 2002

Soluble Receptor-Mediated Targeting of Mouse Hepatitis Coronavirus to the Human Epidermal Growth Factor Receptor

le Würdinger, T., Verheije, M. H., Broen, K., Bosch, B. J., Haijema, B. J., de Haan, C. A. M., van Beusechem, V. W., Gerritsen, W. R., Rottier, P. J. M.
Foilsithe 2005

Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11

le Oosterhoff, D, Overmeer, R M, de Graaf, M, van der Meulen, I H, Giaccone, G, van Beusechem, V W, Haisma, H J, Pinedo, H M, Gerritsen, W R
Foilsithe 2005

Antibody-mediated targeting of viral vectors to the Fc receptor expressed on acute myeloid leukemia cells

le Würdinger, T, Verheije, M H, van der Aa, L M, Bosch, B J, de Haan, C A M, van Beusechem, V W, Gerritsen, W R, Rottier, P J M
Foilsithe in Leukemia (2006)

HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice

le Weimar, I S, Weijer, K, Berk, P C M van den, Muller, E J, Miranda, N, Bakker, A Q, Heemskerk, M H M, Hekman, A, Gast, G C de, Gerritsen, W R
Foilsithe 1999

Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin

le Graat, H C A, Witlox, M A, Schagen, F H E, Kaspers, G J L, Helder, M N, Bras, J, Schaap, G R, Gerritsen, W R, Wuisman, P I J M, van Beusechem, V W
Foilsithe 2006

Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial

le van Werkum, J.W., Gerritsen, W.B.M., Kelder, J.C., Hackeng, C.M., Ernst, S.M., Deneer, V.H.M., Suttorp, M.J., Rensing, B.J.W.M., Plokker, H.W.M., ten Berg, J.M.
Foilsithe 2007

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

le Fradet, Y, Bellmunt, J, Vaughn, D J, Lee, J L, Fong, L, Vogelzang, N J, Climent, M A, Petrylak, D P, Choueiri, T K, Necchi, A, Gerritsen, W, Gurney, H, Quinn, D I, Culine, S, Sternberg, C N, Nam, K, Frenkl, T L, Perini, R F, de Wit, R, Bajorin, D F
Foilsithe in Ann Oncol (2019)

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

le Bellmunt, J., de Wit, R., Vaughn, D.J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N.J., Climent, M.A., Petrylak, D.P., Choueiri, T.K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D.I., Culine, S., Sternberg, C.N., Mai, Y., Poehlein, C.H., Perini, R.F., Bajorin, D.F.
Foilsithe in N Engl J Med (2017)